1. Home
  2. GF vs ACOG Comparison

GF vs ACOG Comparison

Compare GF & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Germany Fund Inc. (The)

GF

New Germany Fund Inc. (The)

N/A

Current Price

$9.80

Market Cap

164.5M

Sector

Finance

ML Signal

N/A

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$8.90

Market Cap

180.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
GF
ACOG
Founded
1990
2000
Country
Germany
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
180.5M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
GF
ACOG
Price
$9.80
$8.90
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $18.20
AVG Volume (30 Days)
16.2K
★ 99.8K
Earning Date
01-01-0001
11-11-2026
Dividend Yield
★ 0.82%
N/A
EPS Growth
N/A
★ 41.58
EPS
★ N/A
N/A
Revenue
N/A
★ $10,220,275.00
Revenue This Year
N/A
$162.31
Revenue Next Year
N/A
$86.08
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.88
$4.50
52 Week High
$12.49
$10.14

Technical Indicators

Market Signals
Indicator
GF
ACOG
Relative Strength Index (RSI) 32.04 52.26
Support Level N/A $7.69
Resistance Level $11.82 $9.30
Average True Range (ATR) 0.23 0.55
MACD -0.04 0.01
Stochastic Oscillator 4.50 65.54

Price Performance

Historical Comparison
GF
ACOG

About GF New Germany Fund Inc. (The)

NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investments includes investments in different sectors such as the industrials, information technology, materials, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: